keyword
Keywords Immunohistochemistry for hepat...

Immunohistochemistry for hepatic metastatic tumors

https://read.qxmd.com/read/37047483/pink1-immunoexpression-predicts-survival-in-patients-undergoing-hepatic-resection-for-colorectal-liver-metastases
#21
JOURNAL ARTICLE
Juan Carlos Celis-Pinto, Adela Alonso Fernández-Velasco, María Daniela Corte-Torres, Jorge Santos-Juanes, Noelia Blanco-Agudín, Kelvin Manuel Piña Batista, Jesús Merayo-Lloves, Luis M Quirós, Iván Fernández-Vega
PTEN-induced kinase-1 (PINK1) is the initiator of the canonical mitophagy pathway. Our aim was to study the immunoexpression of PINK1 in surgical specimens from ninety patients with metastatic colorectal adenocarcinoma (CRC) to the liver (CRLM). Tissue arrays were produced, and immunohistochemical studies were analyzed by the H-Score method. The mean immunoexpression of PINK1 in normal tissues was between 40 to 100 points. In tumoral tissues, positive PINK1 immunoexpression was observed in all samples, and no differences were noted between CRCs...
March 30, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36961477/supporting-biomarker-driven-therapies-in-oncology-a-genomic-testing-cost-calculator
#22
JOURNAL ARTICLE
Albrecht Stenzinger, Brian Cuffel, Noman Paracha, Eric Vail, Jesus Garcia-Foncillas, Clifford Goodman, Ulrik Lassen, Gilles Vassal, Sean D Sullivan
BACKGROUND: Adoption of high-throughput, gene panel-based, next-generation sequencing (NGS) into routine cancer care is widely supported, but hampered by concerns about cost. To inform policies regarding genomic testing strategies, we propose a simple metric, cost per correctly identified patient (CCIP), that compares sequential single-gene testing (SGT) vs. multiplex NGS in different tumor types. MATERIALS AND METHODS: A genomic testing cost calculator was developed based on clinically actionable genomic alterations identified in the European Society for Medical Oncology Scale for Clinical Actionability of molecular Targets...
March 24, 2023: Oncologist
https://read.qxmd.com/read/36211274/case-report-ectopic-thyroid-tissue-found-in-a-liver-with-hepatocellular-carcinoma
#23
Zhanbo Wang, Jing Yuan, Jie Li
Background: Concomitant intrahepatic ectopic thyroid is rare in patients with hepatocellular carcinoma. Thyroid follicular structures outside the hepatocellular carcinoma lesions are regarded as satellite nodules or intrahepatic metastases of hepatocellular carcinoma, which often leads to misdiagnosis and overtreatment of hepatocellular carcinoma patients. Case presentation: We report the case of an 83-year-old man with moderately differentiated hepatocellular carcinoma (2...
2022: Frontiers in Surgery
https://read.qxmd.com/read/36190927/psma-immunohistochemistry-in-hepatic-neoplasms-a-promising-diagnostic-marker-with-potential-theranostic-applications
#24
JOURNAL ARTICLE
Michel Kmeid, Young Nyun Park, Taek Chung, Georgi Lukose, Luz Sullivan, Rupinder Brar, Hwajeong Lee
Accurate classification of well-differentiated hepatocellular neoplasms can be challenging especially in core biopsies. Prostate-specific membrane antigen (PSMA) has been shown to highlight tumor-associated neovasculature in many nonprostatic solid tumors including hepatocellular carcinoma (HCC). Archived 164 hepatectomies and explants with 68 HCCs, 31 hepatocellular adenoma (HA), 24 dysplastic nodules (DN), and 42 metastases were retrieved, and pathologic parameters were evaluated. Sensitivity, specificity, accuracy, positive, and negative predictive values for correct diagnosis of HCC were calculated for PSMA and CD34 immunostains in tissue sections and HCC tissue microarrays...
December 1, 2022: American Journal of Surgical Pathology
https://read.qxmd.com/read/36158651/endothelial-angiopoietin-2-overexpression-in-explanted-livers-identifies-subjects-at-higher-risk-of-recurrence-of-hepatocellular-carcinoma-after-liver-transplantation
#25
JOURNAL ARTICLE
Simone Lasagni, Filippo Leonardi, Alessandra Pivetti, Lorenza Di Marco, Federico Ravaioli, Matteo Serenari, Stefano Gitto, Rosina Maria Critelli, Fabiola Milosa, Adriana Romanzi, Serena Mancarella, Francesco Dituri, Mattia Riefolo, Barbara Catellani, Paolo Magistri, Dante Romagnoli, Ciro Celsa, Marco Enea, Nicola de Maria, Filippo Schepis, Antonio Colecchia, Calogero Cammà, Matteo Cescon, Antonietta d'Errico, Fabrizio di Benedetto, Gianluigi Giannelli, Maria Luz Martinez-Chantar, Erica Villa
Background: Though the precise criteria for accessing LT are consistently being applied, HCC recurrence (HCC-R_LT) still affects more than 15% of the patients. We analyzed the clinical, histopathological, and biological features of patients with HCC to identify the predictive factors associated with cancer recurrence and survival after LT. Methods: We retrospectively analyzed 441 patients with HCC who underwent LT in our center. Overall, 70 (15.8%) of them developed HCC-R_LT...
2022: Frontiers in Oncology
https://read.qxmd.com/read/36132423/use-of-doxorubicin-chemotherapy-following-debulking-surgery-in-the-treatment-of-a-cat-with-mesenteric-hemangiosarcoma
#26
Kerry L Simon, Matthew R Cook, Brian D Husbands, Mackenzie E Long, Jessica A Hokamp, Timothy H Helms, Heather R Shive, Sarah Lumbrezer Johnson, Eric Hostnik, Laura E Selmic
Case summary: A 7-year-old male castrated domestic shorthair cat presented with a 5-day history of inappetence. A mid-abdominal mass was palpated and, on exploratory laparotomy, a cystic mass arising from the root of the mesentery was observed. The mass was drained, debulked and omentalized. Histopathologic examination and immunohistochemistry supported a diagnosis of hemangiosarcoma. Adjuvant doxorubicin was started and, prior to the third of five doses of doxorubicin, repeat abdominal ultrasound showed complete response of the primary tumor...
July 2022: JFMS Open Reports
https://read.qxmd.com/read/36123208/clinical-features-natural-history-and-outcomes-of-pseudolymphoma-of-liver-a-case-series-and-systematic-review
#27
JOURNAL ARTICLE
Wei Jiang, Dongbo Wu, Qin Li, Chang-Hai Liu, Qingmin Zeng, Enqiang Chen, Changli Lu, Hong Tang
BACKGROUND: Pseudolymphoma is a rare, benign, nonspecific condition that forms a mass-like lesion characterized by the proliferation of non-neoplastic lymphocytes. Lacking of specific clinical symptoms, serological markers, and imaging features, the diagnosis is difficult. We reporte five cases of hepatic pseudolymphoma and provide a systematic review of existing literatures to improve our understanding of this rare liver disease. METHODS: We followed-up five cases of hepatic pseudolymphoma in West China Hospital from January 2002 to January 2022...
September 16, 2022: Asian Journal of Surgery
https://read.qxmd.com/read/36051139/solitary-fibrous-tumor-of-the-liver-a-case-report-and-review-of-the-literature
#28
Guang-Yuan Xie, Huan-Bing Zhu, Yun Jin, Bai-Zhou Li, Yuan-Quan Yu, Jiang-Tao Li
BACKGROUND: Hepatic solitary fibrous tumor (SFT) is a rare neoplasm. Up to now, only 90 cases have been reported in the English language literature. This report describes a case of SFT of the liver misdiagnosed as hepatocellular carcinoma. CASE SUMMARY: A 42-year-old male had a two-year history of a gradually enlarging intrahepatic nodule. The preoperative imaging revealed a mass with a size of 2.7 cm × 2.3 cm located in the segment IV of the liver. The patient was subjected to the resection of the segment IV, such as the medial segment of the left lobe of the liver...
July 16, 2022: World Journal of Clinical Cases
https://read.qxmd.com/read/35845511/successful-secondary-radical-operation-on-unretractable-metastatic-platinum-sensitive-recurrent-ovarian-cancer-by-immunotherapy-a-case-report
#29
Li Sun, Hua Li, Sulan Wei, Meng Yang, Shaoqiong Deng
Background: Although rechallenge with platinum-based chemotherapy is effective for most platinum-sensitive recurrent ovarian cancer (ROC) patients, there is still a subset of patients who have no responses to the standard care. Overcoming multidrug resistance (MDR) is a top priority in oncology clinics, but it remains intricate. It is difficult for clinicians to manage unretractable ROC when conventional therapy yields no results. The rational and effective use of immunotherapy will contribute to the clinical benefit of these patients, especially in patients without approved immunotherapy biomarkers...
June 2022: Annals of Translational Medicine
https://read.qxmd.com/read/35782370/liver-biochemical-flare-with-immune-checkpoint-therapy-in-metastatic-merkel-cell-carcinoma-a-liver-biopsy-is-always-necessary
#30
Ibrahim Al-Rajhi, Mahmoud Omar, David Farnell, Saumya Jayakumar, Davedeep Sohi, Eric M Yoshida
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma of the skin. Treatment for locoregional MCC includes local excision with regional lymphadenectomy, followed by adjuvant radiotherapy. Immune checkpoint inhibitors (ICI) have emerged as a breakthrough treatment of metastatic MCC. Nevertheless, T-cell immune response is triggered against self-antigens resulting in immune-mediated toxicities, including ICI-mediated hepatotoxicity. We report a case of recurrent metastatic MCC treated with avelumab, a PD-L1 inhibitor, with subsequent significant liver biochemical flare...
January 2022: Hepatol Forum
https://read.qxmd.com/read/35702580/differential-diagnosis-in-rosai-dorfman-disease-a-rare-case-of-isolated-hepatic-presentation-mimicking-a-metastatic-tumor-with-positive-18-fdg-uptake
#31
JOURNAL ARTICLE
Carlo Gazia, Luca Giordano, Maria Grazia Diodoro, Iacopo Compalati, Riccardo Avantifiori, Gian Luca Grazi
Rosai-Dorfman disease (RDD) is also called sinus histiocytosis with massive lymphadenopathy, and it is caused by a histiocytic disorder with unclear etiology. It usually involves cervical lymph nodes, but it may also present with extranodal involvement. We report a rare condition of isolated hepatic RDD without nodal involvement, clinically manifested with three-month abdominal pain and tenderness of the right hypochondrium. CT- and PET-CT scans were compatible with a secondary lesion from an unknown primary tumor...
May 2022: Intractable & Rare Diseases Research
https://read.qxmd.com/read/35698738/hepatic-carcinoma-expressing-inhibin-case-report-of-a-proposed-novel-entity-and-review-of-the-literature
#32
JOURNAL ARTICLE
Antonia Syrnioti, Evangelia Athanasiou, Prodromos Hytiroglou
Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman presenting with epigastric and back pain. The tumor was located in the left hepatic lobe and measured 12 cm in diameter. On immunohistochemical stains, the neoplastic cells were positive for inhibin, as well as cytokeratins 7, 8/18 and 19...
July 2022: Journal of Pathology and Translational Medicine
https://read.qxmd.com/read/35681273/molecular-deciphering-of-primary-liver-neuroendocrine-neoplasms-confirms-their-distinct-existence-with-foregut-like-profile
#33
JOURNAL ARTICLE
Louis de Mestier, Rémy Nicolle, Nicolas Poté, Vinciane Rebours, François Cauchy, Olivia Hentic, Frédérique Maire, Maxime Ronot, Rachida Lebtahi, Alain Sauvanet, Valérie Paradis, Philippe Ruszniewski, Anne Couvelard, Jérôme Cros
Isolated hepatic localizations of neuroendocrine tumors (NETs) are generally considered as metastatic NETs of unknown primary but could correspond to primary hepatic NETs (PHNETs), a poorly explored entity. We aimed to describe the clinicopathological and molecular features of PHNETs and compare them with other primary NETs. We assembled a retrospective cohort of patients managed for hepatic localization of NET without extra-hepatic primary tumor after exhaustive clinical, imaging, and immunohistochemical characterization...
September 2022: Journal of Pathology
https://read.qxmd.com/read/35476635/epidermal-growth-factor-receptor-immunohistochemical-expression-in-hepatocellular-carcinoma-without-epidermal-growth-factor-receptor-exons-18-21-mutations
#34
JOURNAL ARTICLE
Dafina Nikolova, Meri Trajkovska, Emilija Nikolovska Trpcevska, Aleksandar Eftimov, Rubens Jovanovik, Vesna Janevska
Introduction: EGFR targeted therapies, have been proved beneficial for patients with HCC, nevertheless additional research on EGFR immunoexpresion and EGFR mutations is still needed, especially in population in which it has not been done yet. The aim of this study is to evaluate EGFR immunoexpression in HCC without EGFR exons 18-21 mutations and to evaluate its influence on survival in HCC patients in North Macedonia. Methods: We studied 31 cases of HCC for EGFR immunohistochemical expression and EGFR exons 18-21 mutations...
September 1, 2022: Romanian Journal of Internal Medicine
https://read.qxmd.com/read/35451474/hept1-derived-murine-models-of-high-risk-hepatoblastoma-display-vascular-invasion-metastasis-and-circulating-tumor-cells
#35
JOURNAL ARTICLE
Sarah E Woodfield, Brandon J Mistretta, Roma H Patel, Aryana M Ibarra, Kevin E Fisher, Stephen F Sarabia, Ilavarasi Gandhi, Jacquelyn Reuther, Zbigniew Starosolski, Andrew Badachhape, Jessica Epps, Barry Zorman, Aayushi P Shah, Samuel R Larson, Rohit K Srivastava, Yan Shi, Andres F Espinoza, Saiabhiroop R Govindu, Richard S Whitlock, Kimberly Holloway, Angshumoy Roy, Pavel Sumazin, Ketan B Ghaghada, Dolores Lopez-Terrada, Preethi H Gunaratne, Sanjeev A Vasudevan
Hepatoblastoma (HB) is the most common pediatric primary liver malignancy, and survival for high-risk disease approaches 50%. Mouse models of HB fail to recapitulate hallmarks of high-risk disease. The aim of this work was to generate murine models that show high-risk features including multifocal tumors, vascular invasion, metastasis, and circulating tumor cells (CTCs). HepT1 cells were injected into the livers or tail veins of mice, and tumor growth was monitored with magnetic resonance and bioluminescent imaging...
September 15, 2022: Biology Open
https://read.qxmd.com/read/34799482/sinusoidal-growth-pattern-of-hepatic-melanoma-metastasis-implications-for-histopathologic-diagnosis
#36
JOURNAL ARTICLE
Julianne M Szczepanski, Mishal Mendiratta-Lala, Jiayun M Fang, Won-Tak Choi, Dipti M Karamchandani, Maria Westerhoff
Metastatic tumors interface with liver in multiple patterns, of which, the rare "sinusoidal" growth pattern can be subtle and easily overlooked on biopsy. We sought to characterize the metastasis-to-liver interface patterns of melanoma compared with other tumor types and assess the incidence of metastatic melanoma in histologically normal-appearing targeted liver lesion biopsies. Liver lesion samples from 54 melanoma patients were assessed. Nearly normal-appearing cases, defined as no obvious malignancy on routine hematoxylin and eosin stain (n=24), were stained with SOX10 and confirmed with MelanA...
November 18, 2021: American Journal of Surgical Pathology
https://read.qxmd.com/read/34794407/expression-of-cib1-correlates-with-colorectal-liver-metastases-but-not-with-peritoneal-carcinomatosis
#37
JOURNAL ARTICLE
Sven Jacob, Florian Bösch, Markus B Schoenberg, Elise Pretzsch, Christopher Lampert, Ren Haoyu, Bernhard W Renz, Marlies Michl, Jörg Kumbrink, Thomas Kirchner, Jens Werner, Martin K Angele, Jens Neumann
BACKGROUND: Molecular differences in colorectal cancer (CRC) are associated with the metastatic route. Patient survival is mainly driven by metastatic spread thus it is imperative to understand its key drivers to develop biomarkers for risk stratification, follow-up protocols and personalized therapy. Thus, this study aimed to identify genes associated with the metastatic route in CRC. MATERIAL AND METHODS: CRC patients resected at our clinic from 2005 to 2014 and with a minimum 5-year follow-up were included in this analysis and grouped into CRC with hepatic (HEP), peritoneal (PER) or without distant metastases (M0), and HEP/PER...
November 18, 2021: BMC Cancer
https://read.qxmd.com/read/34307573/liver-metastasis-as-the-initial-clinical-manifestation-of-sublingual-gland-adenoid-cystic-carcinoma-a-case-report
#38
Xiao-Hong Li, Yu-Tao Zhang, Hao Feng
BACKGROUND: Adenoid cystic carcinoma (ACC) is a common malignant tumor of salivary gland. The lung and liver are frequent sites of distant metastasis. Liver metastasis as the initial clinical manifestation of sublingual gland ACC is very rare. CASE SUMMARY: A 51-year-old Chinese woman presented with a painless mass in the right lobe of liver. The tumor was composed of ductal cells and myoepithelial cells with a morphology including tubiform and cribriform structures...
July 6, 2021: World Journal of Clinical Cases
https://read.qxmd.com/read/34306897/liver-granulocytic-sarcoma-with-megakaryocytic-differentiation-a-rare-extra-medullary-involvement-that-warrants-liver-biopsy-for-prompt-diagnosis
#39
Hira Chaudhary, Haytham Aboushi, Jeremy Minkowitz, Jodi-Ann Edwards, Daniel Beltre, Priyanka Parmar, Igal Breitman, Carol Luhrs, Samy I McFarlane
Granulocytic sarcoma (GS) is an extramedullary manifestation of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or myeloproliferative neoplasms. The diagnosis depends on morphology, immunohistochemistry and flow cytometry. An unusual location of this tumor may mask its primary source, therefore, a strategy involving immediate symptom control, and investigation is crucial in preventing clinical deterioration. We present a case of a 53-year-old man who initially presented with tumor lysis syndrome and transaminitis, with a subsequent CT Scan that revealed multiple liver lesions...
July 2021: Curēus
https://read.qxmd.com/read/33994539/calcifying-nested-stromal-epithelial-tumor-a-clinicopathologic-and-molecular-genetic-study-of-eight-cases-highlighting-metastatic-potential-and-recurrent-ctnnb1-and-tert-promoter-alterations
#40
JOURNAL ARTICLE
David J Papke, Fei Dong, Xuchen Zhang, Rafal Kozielski, Olca Basturk, Christopher D M Fletcher, Lei Zhao
Calcifying nested stromal-epithelial tumor (CNSET) is a rare hepatic tumor that occurs in children and young adults. With <40 cases in the literature, the mechanism for tumorigenesis and the biological behavior of CNSET remain uncertain. Here, we studied the clinicopathologic and molecular genetic features of eight CNSETs. Six patients (75%) were female, and the median age at presentation was 22.5 years (range 14-34 years). The median tumor size was 14 cm (range 2.7-18 cm). All tumors had fibrous stroma that contained organoid nests of epithelioid to spindled tumor cells with moderate amounts of palely eosinophilic cytoplasm and ovoid, vesicular nuclei...
September 2021: Modern Pathology
keyword
keyword
82727
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.